* Developed: United States, Japan, Germany, France, Italy, Spain, U.K., Canada, South Korea. Pharmerging** (pharmacy concentration and emerging) China, Brazil, Russia, India, Algeria, Argentina, Colombia, Egypt, Indonesia, Mexico, Nigeria, Pakistan, Poland, Romania, Saudi Arabia, South Africa, Thailand, Turkey, Ukraine, Venezuela, Vietnam. Class forecasts adapted from IMS market forecast September 2014. Expenditures in U.S. dollars with variable exchange rates. Growth in U.S. dollars with constant exchange rates.
This statistic shows the amount of spending related to diabetes in developed and emerging pharmaceutical markets between 2013 and 2018. In 2013, the diabetes market in developed countries spent 35 billion U.S. dollars. Among other factors, the growth in spending is driven by the increase in the price of modern insulin in the United States. In developed markets, new therapies for combating diabetes are a significant driver of market growth.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
IMS Health (Institute for Healthcare Informatics). (November 24, 2014). Diabetes-related expenditures in developed countries and "pharmerging" countries from 2013 to 2018 (in billions of U.S. dollars)* [Graph]. In Statista. Retrieved May 08, 2026, from https://www.statista.com/statistics/1639536/global-spending-on-diabetes-by-market-20132018/
IMS Health (Institute for Healthcare Informatics). "Diabetes-related expenditures in developed countries and "pharmerging" countries from 2013 to 2018 (in billions of U.S. dollars)*." Chart. November 24, 2014. Statista. Accessed May 08, 2026. https://www.statista.com/statistics/1639536/global-spending-on-diabetes-by-market-20132018/
IMS Health (Institute for Healthcare Informatics). (2014). Diabetes-related expenditures in developed countries and "pharmerging" countries from 2013 to 2018 (in billions of U.S. dollars)*. Statista. Statista Inc.. Accessed: May 08, 2026. https://www.statista.com/statistics/1639536/global-spending-on-diabetes-by-market-20132018/
IMS Health (Institute for Healthcare Informatics). "Diabetes-related Expenditures in Developed Countries and "Pharmerging" Countries from 2013 to 2018 (in Billions of U.S. Dollars)*." Statista, Statista Inc., 24 Nov 2014, https://www.statista.com/statistics/1639536/global-spending-on-diabetes-by-market-20132018/
IMS Health (Institute for Healthcare Informatics), Diabetes-related expenditures in developed countries and "pharmerging" countries from 2013 to 2018 (in billions of U.S. dollars)* Statista, https://www.statista.com/statistics/1639536/global-spending-on-diabetes-by-market-20132018/ (last visited May 08, 2026)
Diabetes-related expenditures in developed countries and "pharmerging" countries from 2013 to 2018 (in billions of U.S. dollars)* [Graph], IMS Health (Institute for Healthcare Informatics), November 24, 2014. [Online]. Available: https://www.statista.com/statistics/1639536/global-spending-on-diabetes-by-market-20132018/
